Cargando…
Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective
The main goal of periodontology is to prevent and arrest gingivitis and periodontitis to avoid tooth loss and focal infection of periodontal origin. Periodontal scaling or flap surgery of moderate‐to‐severe periodontitis have shortcomings, most likely because removal of herpesviruses and bacterial p...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804657/ https://www.ncbi.nlm.nih.gov/pubmed/35913496 http://dx.doi.org/10.1111/prd.12463 |
_version_ | 1784862159612674048 |
---|---|
author | Slots, Jørgen |
author_facet | Slots, Jørgen |
author_sort | Slots, Jørgen |
collection | PubMed |
description | The main goal of periodontology is to prevent and arrest gingivitis and periodontitis to avoid tooth loss and focal infection of periodontal origin. Periodontal scaling or flap surgery of moderate‐to‐severe periodontitis have shortcomings, most likely because removal of herpesviruses and bacterial pathogens in deep periodontal lesions and the adjacent inflamed gingiva requires systemic antimicrobial treatment (or gingivectomy). Valacyclovir (1000 mg twice daily on day 1, and 500 mg twice daily on day 2 and on day 3) is a potent anti‐herpesvirus agent. Antibiotic combinations against bacterial pathogens include amoxicillin‐metronidazole (250 mg of each, thrice daily for 4 days; for systemically healthy adults) and ciprofloxacin‐metronidazole (500 mg of each, twice daily for 4 days; for immunosuppressed individuals and patients exposed to contaminated water and poor sanitation). Supportive antiseptic treatment may consist of 0.1%‐0.2% sodium hypochlorite (regular household bleach) as cooling spray in ultrasonic scalers, flosser fluid in oral irrigators, and mouthrinse in patient self‐care. The anti‐infective treatment described here helps control cases of severe periodontitis and constitutes an exceedingly inexpensive alternative to conventional (mechanical) periodontal therapy. |
format | Online Article Text |
id | pubmed-9804657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98046572023-01-06 Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective Slots, Jørgen Periodontol 2000 Commentary The main goal of periodontology is to prevent and arrest gingivitis and periodontitis to avoid tooth loss and focal infection of periodontal origin. Periodontal scaling or flap surgery of moderate‐to‐severe periodontitis have shortcomings, most likely because removal of herpesviruses and bacterial pathogens in deep periodontal lesions and the adjacent inflamed gingiva requires systemic antimicrobial treatment (or gingivectomy). Valacyclovir (1000 mg twice daily on day 1, and 500 mg twice daily on day 2 and on day 3) is a potent anti‐herpesvirus agent. Antibiotic combinations against bacterial pathogens include amoxicillin‐metronidazole (250 mg of each, thrice daily for 4 days; for systemically healthy adults) and ciprofloxacin‐metronidazole (500 mg of each, twice daily for 4 days; for immunosuppressed individuals and patients exposed to contaminated water and poor sanitation). Supportive antiseptic treatment may consist of 0.1%‐0.2% sodium hypochlorite (regular household bleach) as cooling spray in ultrasonic scalers, flosser fluid in oral irrigators, and mouthrinse in patient self‐care. The anti‐infective treatment described here helps control cases of severe periodontitis and constitutes an exceedingly inexpensive alternative to conventional (mechanical) periodontal therapy. John Wiley and Sons Inc. 2022-08-01 2022-10 /pmc/articles/PMC9804657/ /pubmed/35913496 http://dx.doi.org/10.1111/prd.12463 Text en © 2022 The Author. Periodontology 2000 published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Commentary Slots, Jørgen Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective |
title | Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective |
title_full | Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective |
title_fullStr | Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective |
title_full_unstemmed | Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective |
title_short | Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective |
title_sort | concise evaluation and therapeutic guidelines for severe periodontitis: a public health perspective |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804657/ https://www.ncbi.nlm.nih.gov/pubmed/35913496 http://dx.doi.org/10.1111/prd.12463 |
work_keys_str_mv | AT slotsjørgen conciseevaluationandtherapeuticguidelinesforsevereperiodontitisapublichealthperspective |